Anixa Biosciences Inc — Director's Dealing 2013

Mar 20, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2013-02-15

Reporting Person: Titterton Lewis H jr (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-02-15	Employee Stock Options (Right to Buy)	$0.235	A	1000000	Acquired	2023-02-15	Common Stock (1000000)	Direct

Footnotes

F1: On February 15, 2013, the reporting person was granted an option to purchase 1,000,000 shares of common stock. Options for 333,334 are immediately vested and the balance vests in two equal annual installments commencing on February 15, 2014.